Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with neovascular glaucoma (a type of eye condition where abnormal blood vessels block fluid drainage, raising pressure in the eye)
- People who have already received treatment with a medicine called aflibercept, given by injection into the eye, following the approved guidelines used in Japan
Who may not be able to join:
- People for whom this medicine is considered unsafe or not recommended based on the official approved guidelines for the drug
- People whose eye condition has been diagnosed as something other than neovascular glaucoma
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (+)1-888-84 22937
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The number of participants with adverse events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.